Abstracts Archive - Page 809 of 1683 - ATC Abstracts

2018 American Transplant Congress
Comparison of Glycemic Control in Type 1 and Type 2 Diabetic Patients after Pancreas Transplantation
O. Andacoglu,¹ A. Murthy,² J. Ahn,³ J. Verbesey,¹ S. Ghasemian,¹ M. Cooper,¹ P. Abrams.¹
¹Transplant, Medstar Georgetown Transplant Institute, Washington, DC; ²School of Medicine, Georgetown University, Washington, DC; ³Biopstatistics, Georgetown University, Washington, DC.
Background: Pancreas transplant remains controversial for type 2 diabetic (T2DM) patients.Aim: To compare glycemic control following pancreas transplantation between T1 and T2 DM patients.Methods: 52…
2018 American Transplant Congress
Estimation of Beta Cell Function after Total Pancreatectomy with Islet Autotransplantation Using Single Fasting Blood Sample Based Indices and Modified Igls Score.
J. Gołębiewska,¹ P. Bachul,² L. Basto,² M. Kijek,² N. Fillman,² K. Cieply,² K. Golab,² L. Wang,² M. Tibudan,² C. Thomas,³ A. Dębska-Ślizień,¹ J. Fung,² P. Witkowski.²
¹Nephrology, Transplantology and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland; ²Surgery, University of Chicago, Chicago; ³Medicine, University of Chicago, Chicago.
Background: For precise yet logistically feasible evaluation of beta-cell function after total pancreatectomy with islet autotransplantation (TPIAT), we investigated the utility of indices using only…
2018 American Transplant Congress
BETA-2 Score is an Excellent Tool for Monitoring of Islet Allograft Function and Early Detection of Transplant Dysfunction
P. Bachul,¹ J. Gołębiewska,² L. Basto,¹ M. Kijek,¹ N. Fillman,¹ K. Cieply,¹ K. Golab,¹ L-.J. Wang,¹ M. Tibudan,¹ C. Thomas,¹ A. Dębska-Ślizień,² J. Fung,¹ P. Witkowski.¹
¹Surgery, University of Chicago, Chicago; ²Nephrology, Medical University of Gdańsk, Gdańsk, Poland.
After validation of BETA-2 scores in our cohort of patients in relation to standard stimulation tests, we decided to assess the practical utility of BETA-2…
2018 American Transplant Congress
Early Infectious Complications Post Total Pancreatectomy with Islet Autotransplantation
J. Gołębiewska,¹ P. Bachul,² L. Basto,² M. Kijek,² N. Fillman,² K. Cieply,² K. Golab,² L. Wang,² M. Tibudan,² C. Thomas,³ A. Dębska-Ślizień,¹ J. Fung,² P. Witkowski.²
¹Nephrology, Transplantology and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland; ²Surgery, University of Chicago, Chicago; ³Medicine, University of Chicago, Chicago.
Introduction: We decided to assess infectious complications in patients after total pancreatectomy with islet autotransplantation (TPIAT) and check whether positive microbiological results of the islet…
2018 American Transplant Congress
Early Predictors of Metabolic Outcomes in TPIAT
M. Kanak,¹ Y. Shindo,¹ M. Levy.^1,2
¹Surgery, Virginia Commonwealth University, Richmond, VA; ²Hume-Lee Transplant Center, VCU Health System, Richmond, VA.
BackgroundTotal Pancreatectomy with Islet Auto-transplantation (TPIAT) has been actively performed on patients with severe, debilitating pain of chronic pancreatitis or recurrent acute pancreatitis. It is…
2018 American Transplant Congress
Obese Patients Show Resistance to Narcotics Reduction after TPIAT for Chronic Pancreatitis
G. Yoshimatsu,¹ B. Naziruddin,³ K. Kumano,² H. Fernandez,³ E. Beecherl,³ N. Onaca.³
¹Fukuoka University, Fukuoka, Japan; ²Baylor Scott and White Research Institute, Dallas; ³Baylor Simmons Transplant Institute, Dallas.
Total pancreatectomy with islet autotransplantation (TPIAT) is an effective treatment option for chronic pancreatitis patients with refractory pain. Patients with high BMI (>30) are known…
2018 American Transplant Congress
Pancreatic Graft Loss after Simultaneous Pancreas Kidney (SPK) Transplant within First 90 Days. Predictors beyond the Surgical Cause. A UNOS/OPTN Data Analysis
H. Sharma, M. Abraham, J. Chen, D. Mikhail, S. Aquil, S. Patel, A. Skaro, V. McAlister, A. Sener, P. Luke.
Multi-Organ Transplantation Unit, University of Western Ontario, London, ON, Canada.
Background: Data on causal effects of variables to predict the early pancreatic graft loss in first 90 days is limited.Aim: To predict the early pancreatic…
2018 American Transplant Congress
Increased Risk of Early Graft Loss in Pancreas Transplant: A Retrospective Review of the UNOS Database
E. Steen,¹ C. Liu,² E. Siskind,² J. Ortiz.¹
¹Surgery, University of Toledo Medical Center, Toledo, OH; ²Surgery, Inova Fairfax Hospital, Annandale, VA.
Introduction: Pancreas transplant is an established cure for Type 1 diabetes. Nonetheless, early graft loss is not infrequent. We sought to analyze all of the…
2018 American Transplant Congress
Insulin Use after Pancreas Transplant: Implications for Post-Transplant Outcomes
R. Ouseph, K. Lentine,¹ Z. Zhang,¹ D. Axelrod,² H. Randall,¹ B. Kasiske,³ A. Israni,³ V. Dharnidharka,⁴ T. Alhamad,⁴ D. Brennan,⁵ D. Segev,⁵ G. Hess,⁶ M. Schnitzler.¹
¹Saint Louis Univ, St. Louis; ²Lahey Clinic, Burlington; ³Hennepin County Med Center, Minneapolis; ⁴Washington Univ, St. Louis; ⁵Johns Hopkins, Baltimore; ⁶Symphony Health, Conshohocken.
We examined associations of insulin use after pancreas transplant with patient survival, and with kidney graft survival among simultaneous kidney-pancreas transplant (SKPT) recipients, in a…
2018 American Transplant Congress
Pregnancies in Female Pancreas Transplant Alone Recipients
P. Patel,¹ D. Kliniewski,² L. Coscia,² D. Armenti,² S. Constantinescu,^2,3 M. Moritz.^1,2,4
¹Surgery, Lehigh Valley Health Network, Allentown, PA; ²Transplant Pregnancy Registry International, Gift of Life Institute, Philadelphia; ³Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA; ⁴Surgery, Morsani College of Medicine, Tampa, FL.
This is the first series report of pregnancies after pancreas transplant alone (PTA). Data were collected by the Transplant Pregnancy Registry International (TPR) via questionnaires,…